Publicaciones (92) Publicaciones de Javier Guillermo Cassinello Espinosa

2024

  1. Exploring Biomarkers in Breast Cancer: Hallmarks of Diagnosis, Treatment, and Follow-Up in Clinical Practice

    Medicina (Lithuania), Vol. 60, Núm. 1

2023

  1. Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review)

    Oncology reports, Vol. 50, Núm. 6

2022

  1. A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

    European Journal of Cancer, Vol. 175, pp. 110-119

2021

  1. Cáncer de próstata

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 26, pp. 1454-1466

  2. Cáncer de vejiga

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 26, pp. 1441-1453

  3. Cáncer renal

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 26, pp. 1431-1440

  4. Cáncer renal avanzado. Manejo a propósito de un caso

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 26, pp. 1491-1492

  5. First-Line Biological Agents Plus Chemotherapy in Older Patients with Metastatic Colorectal Cancer: A Retrospective Pooled Analysis

    Drugs and Aging, Vol. 38, Núm. 3, pp. 219-231

  6. Optimal treatment sequencing of abiraterone acetate plus prednisone and enzalutamide in patients with castration-resistant metastatic prostate cancer: A systematic review and meta-analysis

    Cancer Treatment Reviews, Vol. 93

  7. Protocolo de práctica asistencial del dolor oncológico

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 26, pp. 1477-1482

  8. Protocolo diagnóstico de las anemias en el paciente oncológico

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 26, pp. 1483-1490

  9. Protocolo diagnóstico y terapéutico de la enfermedad ósea tumoral metastásica

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 26, pp. 1473-1476

  10. Tumores germinales

    Medicine: Programa de Formación Médica Continuada Acreditado, Serie 13, Núm. 26, pp. 1467-1472

2020

  1. Latest progress in molecular biology and treatment in genitourinary tumours

    Clinical and Translational Oncology, Vol. 22, Núm. 12, pp. 2175-2195

2019

  1. BOMET-QoL-10 questionnaire for breast cancer patients with bone metastasis: the prospective MABOMET GEICAM study

    Journal of Patient-Reported Outcomes, Vol. 3, Núm. 1

  2. Prospective Observational Study of Pazopanib in Patients with Advanced Renal Cell Carcinoma (PRINCIPAL Study)

    Oncologist, Vol. 24, Núm. 4, pp. 491-497

  3. Sunitinib rechallenge in advanced renal cell carcinoma: outcomes of a multicenter retrospective study

    Cancer Chemotherapy and Pharmacology, Vol. 84, Núm. 4, pp. 781-789

2018

  1. Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG

    Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 392-401

  2. Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017) (Clinical and Translational Oncology, (2018), 20, 1, (57-68), 10.1007/s12094-017-1783-2)

    Clinical and Translational Oncology

  3. Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii286